Healthcare Business

health care

Goldman Sachs Analyst Neutral Rating of MannKind Feels Like Downgrade

There had been some brief hopes that the worst was over for struggling MannKind Corp. (NASDAQ: MNKD). It turns out that not all great FDA approvals end up being great ...
Read Full Story »
Ebola Virus

Ebola Stock Fallout Severe on Monday

Is the Ebola scare over in the United States? Probably not by a long shot. That being said, Ebola fears are subsiding on Monday as dozens of people came off ...
Read Full Story »
Merger

NewLink Scores Major Partners With Roche’s Genentech

NewLink Genetics Corp. (NASDAQ: NLNK) announced that it has entered into an exclusive worldwide license agreement with Genentech, a member of the Roche Group, for the development of NLG919, NewLink's ...
Read Full Story »
research

Merrill Lynch’s 5 Destroyed Biotech Stocks With 100% or More Upside Potential

While Friday was a welcome relief for shell-shocked stock investors, much of the damage that has been inflicted since the start of the quarter is still weighing on some top ...
Read Full Story »
Ebola Virus

Ebola Stocks Move in Different Directions

Recently we have seen a surge in Ebola-related stocks across the board, but Friday trading brings a mixed view for this group. Allied Healthcare Products Inc. (NASDAQ: AHPI) in Friday ...
Read Full Story »
Ebola Virus

Ebola Stocks on the Move

Investors fan the flames of Ebola fears in the market, enabling these biotech companies to profit from these fears. Ultimately these fears and some hopes of potential contracts or increased ...
Read Full Story »
Biotechnology word cloud

Analyst Top Biotech Stocks Could Explode After Huge Sell-Off

When people are selling first and asking questions later, that is the exact time when savvy investors start to nibble at top stocks that have been hammered. As we reported ...
Read Full Story »
Johnson & Johnson Logo

Drug Sales Energize Johnson & Johnson Earnings

Johnson & Johnson (NYSE: JNJ) reported third-quarter 2014 results before markets opened Tuesday. The health care giant reported adjusted diluted earnings per share (EPS) of $1.50 on revenue of $18.47 ...
Read Full Story »
Ebola Virus

Ebola Fears Driving Ebola Stock Winners

Fears of Ebola have plagued the United States since late September, and some biotech companies have capitalized on this fear. These fears and some hopes of potential contracts or increased ...
Read Full Story »
Biotechnology word cloud

UBS Very Positive on Top Biotech Stocks Ahead of Earnings

The recent market sell-off spared no sector, and the top biotechnology stocks were treated with their own trip to the woodshed. Rising trends in prescriptions and higher, yet beatable increases ...
Read Full Story »
Pills

Diplomat Turns Bunt Pricing Into Homerun for IPO Buyers

Diplomat Pharmacy Inc. (NYSE: DPLO) priced 13.3 million initial public offering (IPO) shares at $13 on Thursday, below the expected range of $14 to $16. When the stock began trading ...
Read Full Story »
Biotechnology word cloud

Short Interest in Biotech Becomes Company Specific

The short interest data are out for the end of September settlement date. Biotech companies are considered a riskier group of stocks with big upside and big downside. FDA rulings ...
Read Full Story »
Hazmat

How Much More Can Lakeland Rise?

Lakeland Industries Inc. (NASDAQ: LAKE) has skyrocketed since the beginning of October. Investors are taking a pessimistic view on recent Ebola news and hedging their bets that it very well ...
Read Full Story »
buy sell

Unilife Finds Second Wave

Unilife Corporation (NASDAQ: UNIS) is riding the wave Wednesday as it watches its shares surf into the close. While this stock was up over 50% on Monday, a second wave ...
Read Full Story »
152498601

Histogenics Files for IPO

Histogenics Corp. has filed its S-1 form with the U.S. Securities and Exchange Commission (SEC) for an initial public offering (IPO). No terms were given for this offering but the ...
Read Full Story »